CVE:HIVE

HIVE Blockchain Technologies Stock Forecast, Price & News

C$3.28
-0.27 (-7.61 %)
(As of 09/20/2021 03:03 PM ET)
Add
Compare
Today's Range
C$3.20
C$3.39
50-Day Range
C$2.54
C$4.50
52-Week Range
C$0.32
C$7.25
Volume1.71 million shs
Average Volume4.17 million shs
Market CapitalizationC$1.24 billion
P/E Ratio29.82
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive HIVE News and Ratings via Email

Sign-up to receive the latest news and ratings for HIVE Blockchain Technologies and its competitors with MarketBeat's FREE daily newsletter.


HIVE Blockchain Technologies logo

About HIVE Blockchain Technologies

HIVE Blockchain Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. It is involved in the mining and sale of digital currencies, such as Ethereum, Ethereum Classic, and Bitcoin. The company was formerly known as Leeta Gold Corp. and changed its name to HIVE Blockchain Technologies Ltd. in September 2017. HIVE Blockchain Technologies Ltd. was incorporated in 1987 and is headquartered in Vancouver, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.63 out of 5 stars

Analyst Opinion: 2.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











HIVE Blockchain Technologies (CVE:HIVE) Frequently Asked Questions

Is HIVE Blockchain Technologies a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for HIVE Blockchain Technologies in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HIVE Blockchain Technologies stock.
View analyst ratings for HIVE Blockchain Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than HIVE Blockchain Technologies?

Wall Street analysts have given HIVE Blockchain Technologies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but HIVE Blockchain Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has HIVE Blockchain Technologies' stock been impacted by Coronavirus (COVID-19)?

HIVE Blockchain Technologies' stock was trading at C$0.24 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, HIVE shares have increased by 1,304.3% and is now trading at C$3.30.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for HIVE?

1 analysts have issued 12 month price objectives for HIVE Blockchain Technologies' stock. Their forecasts range from C$4.00 to C$4.00. On average, they anticipate HIVE Blockchain Technologies' share price to reach C$4.00 in the next twelve months. This suggests a possible upside of 21.2% from the stock's current price.
View analysts' price targets for HIVE Blockchain Technologies
or view top-rated stocks among Wall Street analysts.

Who are HIVE Blockchain Technologies' key executives?

HIVE Blockchain Technologies' management team includes the following people:
  • Mr. Frank Edward Holmes, Interim CEO & Exec. Chairman (Age 66, Pay $78k)
  • Mr. Olivier Roussy Newton, Founder & Strategic Advisor
  • Mr. Darcy Daubaras, Chief Financial Officer

Who are some of HIVE Blockchain Technologies' key competitors?

What other stocks do shareholders of HIVE Blockchain Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HIVE Blockchain Technologies investors own include (CGC), Aurora Cannabis (ACB), (HEXO), KushCo (KSHB), Clear Channel Outdoor (CCO), Citius Pharmaceuticals (CTXR), (SCON), Sorrento Therapeutics (SRNE), Nokia (NOK) and Onconova Therapeutics (ONTX).

What is HIVE Blockchain Technologies' stock symbol?

HIVE Blockchain Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "HIVE."

How do I buy shares of HIVE Blockchain Technologies?

Shares of HIVE and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is HIVE Blockchain Technologies' stock price today?

One share of HIVE stock can currently be purchased for approximately C$3.30.

How much money does HIVE Blockchain Technologies make?

HIVE Blockchain Technologies has a market capitalization of C$1.24 billion and generates C$38.53 million in revenue each year.

What is HIVE Blockchain Technologies' official website?

The official website for HIVE Blockchain Technologies is www.hiveblockchain.com.

Where are HIVE Blockchain Technologies' headquarters?

HIVE Blockchain Technologies is headquartered at 1011 McCarthy Boulevard, Milpitas, CA 95035.

How can I contact HIVE Blockchain Technologies?

HIVE Blockchain Technologies' mailing address is 1011 McCarthy Boulevard, Milpitas, CA 95035. The company can be reached via phone at 604-664-1078.


This page was last updated on 9/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.